ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Mexico » Medical Oncology

Top Medical Oncology Prescribers in New Mexico

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GERALD ROBERTSON MD

Medical Oncology

2,061

$125K

187
125 are 65+

13%
patients receiving schedule two controlled substances

34%
patients receiving schedule three controlled substances

2%
prescriptions for patients 65+ for potentially dangerous drugs

18%
prescriptions for brand name drugs

$61
Average prescription price

CLARK HASKINS MD

Medical Oncology

1,235

$485K

166
139 are 65+

23%
patients receiving schedule two controlled substances

13%
patients receiving schedule three controlled substances

1%
prescriptions for patients 65+ for potentially dangerous drugs

21%
prescriptions for brand name drugs

$393
Average prescription price

BERNARD AGBEMADZO MD

Medical Oncology

1,227

$776K

184
156 are 65+

11%
patients receiving schedule two controlled substances

7%
patients receiving schedule three controlled substances

2%
prescriptions for patients 65+ for potentially dangerous drugs

19%
prescriptions for brand name drugs

$632
Average prescription price

ANNETTE FONTAINE MD

Medical Oncology

1,221

$634K

186
146 are 65+

24%
patients receiving schedule two controlled substances

11%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

24%
prescriptions for brand name drugs

$519
Average prescription price

DAVID SNYDER MD

Medical Oncology

1,150

$451K

164
128 are 65+

22%
patients receiving schedule two controlled substances

27%
patients receiving schedule three controlled substances

1%
prescriptions for patients 65+ for potentially dangerous drugs

20%
prescriptions for brand name drugs

$392
Average prescription price

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank